Compositions comprising docosahexaenoic acid (DHA) and optionally one or more fatty acids selected from the group consisting of eicosapentaenoic acid (EPA), arachidonic acid (ARA), linoleic acid (LA), and .alpha.-linoleic acid (ALA) are administered to felines for preventing or treating feline inflammatory bowel disease (IBD).